FDAnews
www.fdanews.com/articles/145681-genzyme-launches-diagnosic-to-boost-thyroid-cancer-drug-despite-shortages

Genzyme Launches Diagnosic to Boost Thyroid Cancer Drug, Despite Shortages

April 17, 2012
Genzyme announced a nationwide launch of a new diagnostic to help detect thyroid cancer. The genomic test, called Afirma, is produced by Veracyte, a San Francisco-based molecular diagnostics company.
Boston Business Journal